MANAMA, Bahrain, Dec. 02, 2023 (GLOBE NEWSWIRE) — Bahrain has become the second country in the world and the first in the Middle East to approve the use of CASGEVY (exagamglogene autotemcel) for the treatment of patients with sickle cell disease and transfusion-dependent beta-thalassemia. The treatment was developed by Vertex Pharmaceuticals and CRISPR Therapeutics, after […]

SHANGHAI, China, Dec. 01, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Therapeutic Goods Administration of the Australian Government Department of Health and Aged Care (TGA) has accepted the New […]

CHICAGO, Nov. 30, 2023 (GLOBE NEWSWIRE) — Amlan® International, the animal health business of Oil-Dri® Corporation of America (NYSE: ODC) and a global leader in mineral-based feed additives that optimize the intestinal health of poultry and livestock, is pleased to announce an expansion of their presence in the Southern Vietnam market through a new distribution […]

Basildon, December 1, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that on November 30, 2023, S&P Global Ratings raised its long-term issuer credit ratings on CNH Industrial N.V. and its subsidiary, CNH Industrial Capital LLC, to ‘BBB+’ from ‘BBB’. S&P Global Ratings also affirmed the ‘A-2’ short-term issuer credit rating. Additionally, S&P […]

VICTOR, N.Y., Nov. 30, 2023 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its third quarter ended November 30, 2023, on Friday, January 5, 2024, before the open of the U.S. markets. A conference call to discuss the financial results and outlook […]